Scaffolding and Signaling: HOMER3 clusters postsynaptic density proteins, linking glutamate receptors (e.g., GRM1/5) to intracellular calcium channels (ITPR1/RYR1) to regulate calcium signaling . This coupling modulates synaptic plasticity and neuronal excitability .
Gene Regulation: In triple-negative breast cancer (TNBC), HOMER3 facilitates epidermal growth factor (EGF)-induced β-catenin tyrosine phosphorylation by scaffolding c-Src and β-catenin, promoting nuclear translocation and oncogenic signaling .
Mitochondrial Regulation: In non-small cell lung cancer (NSCLC), HOMER3 upregulates GABPB1 to enhance mitochondrial biogenesis and metastasis .
TNBC: Overexpression correlates with metastasis and poor survival .
NSCLC: High HOMER3 levels predict reduced survival; knockdown suppresses proliferation and metastasis in vitro/in vivo .
Autoimmune Cerebellar Ataxia: Anti-HOMER3 antibodies are linked to cerebellar atrophy, encephalopathy, and REM sleep behavior disorder. Clinical features include unsteady gait, slurred speech, and nystagmus .
Mechanism: Autoantibodies disrupt HOMER3-mediated coupling of GRM1 and ITPR1, impairing Purkinje cell calcium homeostasis .
Disease Modeling: Used to study synaptic dysfunction in neurological disorders and oncogenic signaling in cancers .
Therapeutic Targeting: Preclinical studies highlight HOMER3 as a vulnerability in TNBC and NSCLC .
Brain: Enriched in cerebellar Purkinje cells (cytoplasmic expression) .
Peripheral Tissues: Detected in thymus, lung, and cancer cells .
Homer-3 is a postsynaptic scaffolding protein primarily expressed in the dendritic spines of Purkinje cells in the cerebellum. It plays a critical role in cross-linking metabotropic glutamate receptor 1 (mGluR1) to intracellular calcium channels (ITPR1), thereby regulating calcium equilibrium in Purkinje cells in response to mGluR1 activation . In neuroscience research, Homer-3 is significant as autoantibodies against this protein are associated with autoimmune cerebellar ataxia (ACA) and other neurological manifestations, making it an important biomarker for certain autoimmune neurological disorders .
Detection of Homer-3 antibodies in clinical research typically employs both cell-based and tissue-based assays. In tissue-based assays, patient serum or CSF is applied to fixed monkey cerebellum sections, where Homer-3 antibodies will react with the cytoplasm and dendrites of Purkinje cells while sparing the nucleus . This characteristic staining pattern is then confirmed using cell-based assays that express the Homer-3 antigen . These complementary approaches ensure accurate identification of Homer-3 antibodies in research and diagnostic contexts.
Homer-3 antibody-associated disorders present with a spectrum of neurological manifestations. The primary presentation is cerebellar ataxia, characterized by dizziness, unsteady gait, limb ataxia, slurred speech, and nystagmus . Beyond cerebellar symptoms, patients may exhibit:
Clinical Manifestation | Specific Features | Frequency in Studies |
---|---|---|
Cerebellar Ataxia | Dizziness, unsteady gait, limb ataxia, slurred speech, nystagmus | 6/6 patients |
Encephalopathy | Psychosis, seizures, confusion, cognitive impairment | 2/6 patients |
Myeloradiculopathy | Limb weakness, hyporeflexia, denervation on EMG | 2/6 patients |
REM Sleep Behavior Disorder | - | 2/6 patients |
Autonomic Dysfunction | - | 2/6 patients |
Brain MRI findings are variable, ranging from normal appearance to cerebellar atrophy, cerebellum and pons atrophy with the hot cross bun sign, or bilateral cerebral abnormalities .
Homer-3 antibody testing represents one component of a comprehensive diagnostic approach for cerebellar ataxia. While testing for this antibody has high specificity, with negative results in healthy controls and patients with other types of cerebellar ataxia , its relative rarity makes unbiased screening clinically impractical. Diagnostic evaluation should include clinical assessment (onset characteristics, associated symptoms), neuroimaging (MRI patterns), CSF analysis (inflammatory markers), and testing for other autoimmune, paraneoplastic, metabolic, and genetic causes of ataxia . Key distinguishing features suggesting Homer-3 antibody-associated ataxia include acute/subacute onset, cerebral and nerve root involvement, lack of dysautonomia, and inflammatory changes in CSF .
Treatment of Homer-3 antibody-associated disorders centers on immunotherapy. In clinical research, patients have received combinations of intravenous immunoglobulin (IVIg), corticosteroids, plasma exchange, and mycophenolate mofetil . Treatment responses are variable, with most patients (4 out of 6 in one study) showing partial improvement or stabilization of symptoms, while some continue to deteriorate despite immunotherapy .
Treatment Outcome | Proportion of Patients | Notes |
---|---|---|
Partial improvement | 4/6 | Regarding ataxia, weakness, and encephalopathy |
Stabilization | 1/6 | No further progression but no improvement |
Continued deterioration | 1/6 | Despite repeated immunotherapy |
Relapse | 2/4 improved patients | During corticosteroid weaning or after IVIg discontinuation |
Residual disability | 4/6 | Modified Rankin Scale score ≥3 at follow-up |
Long-term outcomes often include significant residual disability, with SARA (Scale for the Assessment and Rating of Ataxia) scores ranging from 12 to 29 at the last follow-up .
Feature | MSA-C | Homer-3 Antibody Disorders | Distinguishing Factors |
---|---|---|---|
Clinical Onset | Insidious | Often subacute/acute | Tempo of symptom development |
Brain/Nerve Involvement | Primarily cerebellar | May have cerebral and nerve root involvement | Distribution of neurological deficits |
CSF Profile | Generally normal | May show inflammatory changes | Presence of leukocytosis, protein elevation, oligoclonal bands |
Response to Treatment | Poor, progressive | May respond to immunotherapy | Therapeutic trial may be diagnostic |
Dysautonomia | Prominent | May be absent or less prominent | Severity of autonomic symptoms |
Distinguishing between these conditions is crucial as MSA-C is a progressively deteriorating neurodegenerative disease without effective treatment, whereas Homer-3 antibody-associated cerebellar syndrome may respond to immunotherapy .
The exact pathophysiological mechanism of Homer-3 antibodies remains incompletely understood. As Homer-3 is an intracellular protein, the antibodies themselves are likely not directly pathogenic, similar to other antibodies targeting intracellular components like anti-Yo and anti-Hu, which showed no pathogenicity in animal experiments . Instead, the neurological damage may be mediated by T lymphocytes .
Homer-3's role in cross-linking mGluR1 to ITPR1 and regulating calcium equilibrium in Purkinje cells suggests that disruption of this pathway could contribute to cerebellar dysfunction . The broader neurological manifestations (encephalopathy, myeloradiculopathy, RBD, dysautonomia) might reflect Homer-3's expression in other neural tissues or epitope spread to additional neuronal antigens.
HOMER3 is an open-source MATLAB application designed for analyzing functional Near-Infrared Spectroscopy (fNIRS) data to obtain estimates and maps of brain activation . It represents an evolution of the well-established HOMER2 software, which itself developed from the Photon Migration Imaging Toolbox dating back to the early 1990s .
Developed and maintained by the Boston University Neurophotonics Center, HOMER3 allows researchers to process fNIRS data, which measures hemodynamic responses in the brain during cognitive tasks or stimuli, similar to fMRI but with different temporal and spatial characteristics. The software provides tools for preprocessing, analysis, and visualization of brain activation patterns derived from optical measurements .
Installation Component | Method | Notes |
---|---|---|
Main HOMER3 Package | Download latest release | Not via "Download .zip" or cloning |
Submodule Libraries | Manual download from respective repositories | Must be placed in the \Homer3 folder |
MATLAB Compatibility | Works with MATLAB 2017b and others | Specific version compatibility not fully detailed |
Support | Homer3 & AtlasViewer community forum on openfnirs.org | For usage questions |
Bug Reports | GitHub issues | For reporting bugs or suggesting features |
Documentation | GitHub wiki | Work in progress |
The software has been used with various MATLAB versions, including MATLAB 2017b with MATLAB Runtime V9.3 .
HOMER3 provides a comprehensive suite of analysis tools for fNIRS data. While the search results don't detail all specific capabilities, HOMER3 enables researchers to analyze fNIRS data to:
Process raw optical data to obtain changes in hemoglobin concentration (HbO, HbR, and HbT)
Compare brain activation between different experimental conditions
Conduct statistical analyses of brain activation data, including p-value calculations
Implement processing streams for data analysis, allowing for customized analysis workflows
The software continues the analytical approaches detailed in previous publications on HomER, which include time-series analysis methods for near-infrared spectroscopy of the brain .
HOMER3 allows researchers to analyze and contrast brain activation across multiple experimental conditions. Based on the search results, researchers can set up their data to include multiple conditions (e.g., "0-back, 1-back, 2-back" in a visual n-back task) with multiple trials per condition .
Experimental Design Element | Implementation in HOMER3 | Example |
---|---|---|
Multiple Conditions | Configurable in processing stream | 0-back, 1-back, 2-back conditions |
Multiple Trials | Multiple instances per condition | 2 trials per condition |
Hemoglobin Species | Separate analysis for each | HbO, HbR, and HbT contrasts |
Statistical Comparison | Between-condition contrasts | Comparing 2-back vs. 0-back |
Results Visualization | P-value display tool | (Note: Some users report issues with this feature) |
The software appears to support creating contrasts between these conditions to examine differences in hemoglobin species activity . Researchers need to properly set up their files and processing stream to enable these comparisons. The interface includes tools for displaying statistical results, such as p-values, although some users have reported difficulties with this functionality .
Based on the limited search results, some challenges researchers face when using HOMER3 include:
Difficulty in interpreting output and locating results of analyses
Challenges in setting up proper file structures and processing streams
Potential difficulties in obtaining meaningful results even when files and processing streams appear to be correctly configured
These challenges may be particularly pronounced for researchers with limited coding experience . The search results suggest that support for users is available via the Homer3 & AtlasViewer community forum hosted on openfnirs.org . Additionally, users can report bugs or suggest features by creating issues on the GitHub repository .
Researchers using HOMER3 in their studies should cite the original publication as specified by the developers :
Huppert, T., Diamond, S., Franceschini, M., Boas, D. (2009). HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain. Applied optics 48(10). https://dx.doi.org/10.1364/ao.48.00d280
While HOMER3 is BSD licensed, the developers specifically request citation of this publication when the software is used in research . Proper attribution ensures recognition of the intellectual contribution of the developers and helps track the software's impact in the scientific community.
Based on best practices in neuroimaging and the available search results, researchers should consider the following steps to ensure reliable and reproducible results when using HOMER3:
Step | Implementation | Purpose |
---|---|---|
Experimental Design | Clear conditions with sufficient trials | Ensure adequate signal-to-noise ratio |
Data Organization | Structure according to HOMER3 requirements | Enable proper software processing |
Preprocessing | Implement appropriate noise reduction steps | Minimize artifacts in fNIRS data |
Processing Stream | Document all analysis parameters | Enable replication by others |
Analysis Verification | Check results against expected patterns | Confirm correct functioning of analysis tools |
Documentation | Share processing streams in publications | Enhance reproducibility |
Contribution | Follow development guidelines for improvements | Help advance the software |
When publishing results, researchers should cite the original HOMER publication and consider sharing their processing streams and analysis parameters to enhance reproducibility for other researchers.
While the search results don't explicitly detail HOMER3's limitations, several challenges can be inferred:
Difficulty in interpreting outputs for users with limited coding experience
Issues with specific functionalities like the p-value display tool
Dependency on MATLAB, which may limit accessibility for some researchers
Future research and development efforts might address these limitations through:
Enhanced documentation with step-by-step tutorials for various analysis scenarios
Improved user interface elements to facilitate result interpretation
Expanded statistical tools with more intuitive visualization options
Development of standalone versions that don't require a MATLAB license
Integration capabilities with other neuroimaging modalities for multimodal analysis
The open-source nature of HOMER3 and the developers' invitation for community contributions provide a framework for addressing these limitations through collaborative efforts from the fNIRS research community.
HOMER3 shares a similar domain structure with other members of the Homer family. It consists of:
These structural features enable HOMER3 to interact with various proteins and contribute to the formation and maintenance of synaptic structures. HOMER3 is particularly important in the postsynaptic density (PSD) of neurons, where it helps regulate the size and strength of synapses .
Synaptic plasticity is the ability of synapses to strengthen or weaken over time in response to changes in activity. This process is essential for learning, memory, and overall brain function. HOMER3, along with other Homer proteins, plays a key role in modulating synaptic plasticity by:
Recombinant HOMER3 is a form of the protein that is produced using recombinant DNA technology. This involves inserting the gene encoding HOMER3 into a host organism, such as E. coli, which then produces the protein. Recombinant HOMER3 is often used in research to study the protein’s structure, function, and interactions with other proteins .
The recombinant human HOMER3 protein typically includes a His-tag at the N-terminus to facilitate purification and detection. It is expressed in E. coli and purified using conventional chromatography techniques .
Recombinant HOMER3 is used in various research applications, including: